Efficacy and tolerability of topical tacrolimus ointment for the treatment of male genital psoriasis

Journal of Cutaneous Medicine and Surgery

Volumn 12, Issue 5, 2008, Pages 230-234

  Bissonnette, Robert ^a   Nigen, Simon ^a   Bolduc, Chantal ^a  

^a INNOVADERM RESEARCH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; APPLICATION SITE PRURITUS; ARTICLE; BURNING SENSATION; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; FOLLOW UP; HUMAN; MALE; MALE GENITAL SYSTEM DISEASE; OINTMENT; OPEN STUDY; PENIS GLANS; PRIORITY JOURNAL; PSORIASIS; PSORIASIS SEVERITY INDEX; SCROTUM; CLINICAL TRIAL; GENITAL SYSTEM DISEASE; MIDDLE AGED; PATHOLOGY; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADULT; AGED; GENITAL DISEASES, MALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PSORIASIS; TACROLIMUS;

EID: 58849142630     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.2310/7750.2008.07055     Document Type: Article

References (18)

1. Koo J. Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. Dermatol Clin 1996; 14:485-96.
2. Fouere S, Adjadj L, Pawin H. How patients experience psoriasis: results from a European survey. J Eur Acad Dermatol Venereol 2005;19 Suppl 3:2-6.
3. Deakin MJ. Current dangers and problems in the topical use of steroids. Med J Aust 1976;1:120-1.
4. Gupta AK, Adamiak A, Chow M. Tacrolimus: a review of its use for the management of dermatoses. J Eur Acad Dermatol Venereol 2002;16:100-14.
5. Caproni M, Torchia D, Antiga E, et al. The effects of tacrolimus ointment on regulatory T lymphocytes in atopic dermatitis. J Clin Immunol 2006;26:370-5.
6. Canadian Product Monograph. Protopic™ Canadian product monograph. Available at: www.hc-sc.gc.ca/dhp-mps/prodpharma/databasdon/ index_e.html (accessed April 8, 2008).
7. Lebwohl M, Freeman A, Chapman MS, et al. Proven efficacy of tacrolimus for facial and intertriginous psoriasis. Arch Dermatol 2005;141:1154.
8. Lebwohl M, Freeman AK, Chapman MS, et al. Tacrolimus ointment is effective for facial and intertriginous psoriasis. J Am Acad Dermatol 2004;51:723-30.
9. Freeman AK, Linowski GJ, Brady C, et al. Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas. J Am Acad Dermatol 2003;48:564-8.
10. Kroft EB, Erceg A, Maimets K, et al. Tacrolimus ointment for the treatment of severe facial plaque psoriasis. J Eur Acad Dermatol Venereol 2005;19:249-51.
11. Steele JA, Choi C, Kwong PC. Topical tacrolimus in the treatment of inverse psoriasis in children. J Am Acad Dermatol 2005;53: 713-6.
12. Yamamoto T, Nishioka K. Topical tacrolimus: an effective therapy for facial psoriasis. Eur J Dermatol 2003;13:471-3.
13. Clayton TH, Harrison PV, Nicholls R, et al. Topical tacrolimus for facial psoriasis. Br J Dermatol 2003;149:419-20.
14. Yamamoto T, Nishioka K. Topical tacrolimus is effective for facial lesions of psoriasis. Acta Derm Venereol 2000;80:451.
15. Zonneveld IM, Rubins A, Jablonska S, et al. Topical tacrolimus is not effective in chronic plaque psoriasis. A pilot study. Arch Dermatol 1998;134:1101-2.
16. Ortonne JP, van de Kerkhof PC, Prinz JC, et al. 0.3% Tacrolimus gel and 0.5% tacrolimus cream show efficacy in mild to moderate plaque psoriasis: results of a randomized, open-label, observer-blinded study. Acta Derm Venereol 2006;86:29-33.
17. Rallis E, Nasiopoulou A, Kouskoukis C, et al. Successful treatment of genital and facial psoriasis with tacrolimus ointment 0.1%. Drugs Exp Clin Res 2005;31:141-5.
18. Ezquerra GM, Regana MS, Acosta EH, et al. Topical tacrolimus for the treatment of psoriasis on the face, genitalia, intertriginous areas and corporal plaques. J Drugs Dermatol 2006;5:334-6.